Back to medical news
OncLive
Armenia Grants First Marketing Authorizations to Botensilimab Plus Balstilimab in Previously Treated MSS mCRC
October 12, 2026
The source didn’t give us enough text to summarize this story. Use “Read original source” above to read it at OncLive.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news